ArticleJournal of clinical pharmacology2026

Leveraging Model Integrated Bioequivalence (MIBE) to Address Regulatory Concerns and Waive Repeat Bioequivalence Studies-A Case Study with Clopidogrel.

Mathangi Gopalakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.